___

• 1. Williams, T.M., Ciccarone, T.M., MacTough, S.C., Rooney, C.S., Balani, S.K., Condra, J.H., Emini, E.A., Goldman, M.E., Greenlee, W.J., Kauffman, L.R., O'Brien, J.A., Sardana, V.V., Schleif, W.A., Theoharides, A.D., Anderson, P.S. "5-Chloro 3 (phenylsulfonyl)indole-2-carboxamide: A Novel, Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase", J. Med. Chem. 36, 1291-1294 (1993)
• 2. Almerico, A.M., Barraja, P., Diana, P., Cirrincione, G., Mingoia, F., Musiu, C, Perra, G., Putzolu, M., Marongiu, M.E. "Glycosidopyrroles Part 3. Effect of the benzocondensation on acyclic derivatives: l-(2-hydroxyethoxy)methylindoles as potential antiviral agents", IL Farmaco, 53, 409-414 (1998)
• 3. Suzen, S., Buyukbingol, E. "Evaluation of anti-HIV activity of 5-(2-phenyl-3'-indolyl)-2- thiohydantoin", IL Farmaco, 53, 525-527 (1998)
• 4. Murphy, R., Montaner, J. "Nevirapine: a review of its development, pharmacological profile and potential for clinical use", Exp. Opin. Invest. Drugs, 5, 1183-1199 (1996)
• 5. Kelly, T.A., McNeil, D.W., Rose, J.M., David, E., Shih, C.-C, Grob, P.M. Novel nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. 6. 2- indol-3-yl- and 2-azaindol-3-yl-dipyridodiazepinones", J. Med. Chem. 40, 2430-2433 (1997)
• 6. Olgen, S., Akaho, E., Nebioğlu, D. "Synthesis and receptor docking studies of /V-substituted indole-2-carboxylic acid esters as a search for COX-2 selective enzyme inhibitors", Eur. J. Med. Chem. 36, 747-770 (2001)
• 7. Weislow, O.W., Kiser, R., Fine, D., Bader, J., Shoemaker, R.H., Boyd, M.R. "New soluble-formazon assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity", J. Natl. Cancer Inst. 81, 577- 586(1988)